BioSpace News Archive

Business

Novo Nordisk and UC San Francisco Pushing Toward a Diabetes Cure

Danish company Novo Nordisk is a leader in diabetes treatment, but this week announced it was upping its commitment to stem-cell-based therapies and expanding its focus.

May 18, 2018

·

2 min read

·

Mark Terry

Policy

Retailers File Lawsuit Against Allergan over Restasis Patents

Allergan has gone to great lengths to defend the patents for its blockbuster dry-eye drug Restasis and it looks like the company will have to head back to court again.

May 18, 2018

·

2 min read

·

Alex Keown

Business

Accent Therapeutics Launches with $40 Million: Focus on RNA-Modifying Proteins

Accent Therapeutics, headquartered in Cambridge, Massachusetts, closed on a $40 million Series A financing. Accent will focus on the fairly new area of epitranscriptomics.

May 18, 2018

·

2 min read

·

Mark Terry

Drug Development

FDA Approves Amgen and Novartis Migraine Drug Aimovig, Expected to Be Ready for Patients in 1 Week

Amgen and Novartis scored a big win in the migraine market late Thursday when the U.S. Food and Drug Administration approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults.

May 18, 2018

·

3 min read

·

Alex Keown

Drug Development

Another One Bites the Dust: J&J Kills Early Alzheimer’s Program

Johnson & Johnson’s Janssen division has decided to end its trials of atabacestat, a BACE inhibitor, for Alzheimer’s disease.

May 18, 2018

·

2 min read

·

Mark Terry

Pivot Accelerates Development of CBD Products for Domestic Pet Market

Based on RTIC Ready-To-Infuse-Cannabis Powder and Thrudermic Transdermal Cream

May 18, 2018

·

4 min read

Drug Development

BerGenBio to Present Interim Clinical and Biomarker Data With Selective AXL Inhibitor Bemcentinib in AML and MDS at EHA

The 23rd Congress of the European Hematology Association (EHA) will take place in Stockholm (14-17 June 2018).

May 18, 2018

·

3 min read

Biotech Bay

Bio-Rad Expedites Disease Biomarker Discovery and Drug Development with the Launch of Bio-Plex Pro Human Cytokine Screening Panel

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the Bio-Plex Pro Human Cytokine Screening Panel, the first validated high-performance multiplex assay on the market.

May 18, 2018

·

4 min read

Drug Development

GTx Updates Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence at 2018 AUA Annual Meeting

GTx, Inc. (Nasdaq: GTXI) today released additional data supporting the durability of the response to a 12-week treatment with enobosarm 3 mg in an open-label, Phase 2 proof-of-concept clinical trial evaluating enobosarm in postmenopausal women with stress urinary incontinence (SUI)...

May 18, 2018

·

7 min read

Working to Improve Hemophilia A Testing: Precision BioLogic to present new data at WFH 2018 World Congress

Precision Biologics will present data at the World Federation of Hemophilia (WFH) 2018 World Congress in Glasgow, Scotland, May 20-24. Recognizing the need to improve Factor VIII (FVIII) inhibitor testing for people with...

May 18, 2018

·

3 min read